Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

molecular risk assessment

(muh-LEH-kyoo-ler risk uh-SES-ment)

A procedure in which biomarkers (for example, biological molecules or changes in tumor cell DNA) are used to estimate a person’s risk for developing cancer. Specific biomarkers may be linked to particular types of cancer.

molecular risk assessment

Search NCI's Dictionary of Cancer Terms